63 related articles for article (PubMed ID: 6484332)
1. [Combined familial hyperlipidemia. Study of a family].
Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
[No Abstract] [Full Text] [Related]
2. A study of familial combined hyperlipidemia in 11 families.
Das SK; Chandra M; Shukla RN; Nityanand S; Agarwal SS
Indian J Med Res; 1983 Nov; 78():665-9. PubMed ID: 6671713
[No Abstract] [Full Text] [Related]
3. Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern.
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Acta Univ Palacki Olomuc Fac Med; 1986; 113():193-216. PubMed ID: 2941985
[No Abstract] [Full Text] [Related]
4. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
[No Abstract] [Full Text] [Related]
5. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
Reynisdottir S; Eriksson M; Angelin B; Arner P
J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
[TBL] [Abstract][Full Text] [Related]
6. [Familial combined hyperlipidemia].
de Bruin TW; Dallinga-Thie GM; Erkelens DW
Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
[No Abstract] [Full Text] [Related]
7. Status of "familial combined hyperlipidemia".
Brunzell JD; Motulsky AG
Prog Clin Biol Res; 1984; 147():403-5. PubMed ID: 6739492
[No Abstract] [Full Text] [Related]
8. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
[TBL] [Abstract][Full Text] [Related]
9. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
10. [Effects of bezafibrate in patients with combined hyperlipidemia].
Vílchez Joya R; Escobar Jiménez F; Campos MM; Torres E; Orduña R; Cabrera J; Núñez J
Med Clin (Barc); 1986 Feb; 86(5):190-4. PubMed ID: 3959651
[No Abstract] [Full Text] [Related]
11. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
[TBL] [Abstract][Full Text] [Related]
12. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
[TBL] [Abstract][Full Text] [Related]
13. Rat model of familial combined hyperlipidemia as a result of comparative mapping.
Ueno T; Tremblay J; Kunes J; Zicha J; Dobesova Z; Pausova Z; Deng AY; Sun YL; Jacob HJ; Hamet P
Physiol Genomics; 2004 Mar; 17(1):38-47. PubMed ID: 14709677
[TBL] [Abstract][Full Text] [Related]
14. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
15. Familial combined hyperlipidemia. Part II. Clinical picture.
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Acta Univ Palacki Olomuc Fac Med; 1986; 114():243-59. PubMed ID: 2946184
[No Abstract] [Full Text] [Related]
16. Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
van der Vleuten GM; Hijmans A; Heil S; Blom HJ; Stalenhoef AF; de Graaf J
Am J Med Genet A; 2006 May; 140(9):1010-2. PubMed ID: 16575890
[No Abstract] [Full Text] [Related]
17. Chylomicronemia induced by cimetidine.
Iverius PH; Brunzell JD
Gastroenterology; 1985 Sep; 89(3):664-6. PubMed ID: 4018506
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
Shen GX; Mymin D; Dembinski T; Krahn A; Angel A
Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
Grundy SM; Vega GL; Yuan Z; Battisti WP; Brady WE; Palmisano J
Am J Cardiol; 2005 Feb; 95(4):462-8. PubMed ID: 15695129
[TBL] [Abstract][Full Text] [Related]
20. The clinical laboratory and hyperlipidemia: a clinician's view.
Wilson DE
Am J Med Technol; 1981 Jul; 47(7):551-8. PubMed ID: 7282762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
